HUM vs INO · P/E 39, rev $129.66B vs rev $65.3K
Humana Inc (HUM) versus Inovio Pharmaceuticals Inc (INO) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Inovio Pharmaceuticals Inc (INO) is a biotechnology company listed on US.
Latest reported HUM revenue for 2025-12-31 was $129.66B. Net income was $1.19B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported INO revenue for 2025-12-31 was $65.3K. Net income was -$84.9M. Revenue was down 70.0% from 2024-12-31 to 2025-12-31. INO currently screens at market cap $88.0M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. INO currently screens at market cap $88.0M.
Not investment advice. Open the HUM and INO stock pages for the full models.
Not investment advice.